Arrhythmias & electrophysiology

Percutaneous left atrial appendage closure following catheter ablation therapy of atrial fibrillation: outcomes stratified by bleeding risk – a sub-analysis of the OPTION study

EuropacePublished Secondary analysis of the OPTION randomised trial

Authors' conclusion

Regardless of bleeding risk, LAAC is comparable to OAC in stroke protection while demonstrating greater freedom from bleeding in a post-ablation AF population, even in patients with low HAS-BLED scores.

Study context

Population
Patients with atrial fibrillation (AF) and high stroke risk undergoing catheter ablation, stratified by HAS-BLED score (0, 1, 2, ≥3)randomized 1:1
Participants
1,600 patients
Comparison
Left atrial appendage closure (LAAC) vs oral anticoagulation (OAC) after catheter ablation of AF
Primary endpoint
Primary effectiveness (all-cause death/stroke/systemic embolism) and safety (bleeding composite) endpoints by HAS-BLED subgroup
Methodological detailspre-specified sub-analysis, stratified by HAS-BLED score
  • Pre-specified sub-analysis
  • Stratified by HAS-BLED score

Primary result

As reported in the abstract

Primary safety bleeding events by HAS-BLED subgroup
LAAC vs OACHazard ratio (95% CI)
HAS-BLED 0 (n = 265)
0.25(0.20–0.50)
HAS-BLED 1 (n = 890)
0.41(0.27–0.61)

Original publication

Percutaneous left atrial appendage closure following catheter ablation therapy of atrial fibrillation: outcomes stratified by bleeding risk – a sub-analysis of the OPTION study. Europace. Published 2 June 2026. doi:10.1093/europace/euag093

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.